Fever, Reduced Ability to Sweat Mega Study
Contents
Fever, Reduced Ability to Sweat
Fever, Reduced Ability to Sweat

Related

A
1 to 5 Rating
A
Symptoms
A
Factors
A
Effects

Tags

Fever
Fever, Reduced Ability To Sweat

Treatments Causing Fever, Reduced Ability to Sweat

User-reported treatments that exhibited the side effect of Fever, Reduced Ability to Sweat

Treatment Percent of Reports
Maxalt 4%
Rizatriptan (Maxalt) 4%

Below is the degree of change seen after Fever, Reduced Ability to Sweat is higher than average.

Below is the change in Fever, Reduced Ability to Sweat seen after the predictor is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.
Predictors
of
Below is the change in after the listed predictor is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change from the average seen after the predictor is higher than average.

Fever, Reduced Ability to Sweat Info

Property Value
Variable Name Fever, Reduced Ability To Sweat
Aggregation Method MEAN
Analysis Performed At 2020-03-02
Duration of Action 24 hours
Maximum Allowed Value 5 out of 5
Minimum Allowed Value 1 out of 5
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 0
Number of Measurements 0
Number of Measurements (including those generated by tagged, joined, or child variables) 0
Public true
Onset Delay 0 seconds
Unit 1 to 5 Rating
User Variables 0
Variable Category Symptoms
Variable ID 87293